Quantitative proteomic analysis of oligodendrogliomas with and without 1p/19q deletion

Journal of Proteome Research

Volumn 9, Issue 5, 2010, Pages 2610-2618

  Rostomily, Robert C ^a   Born, Donald E ^a   Beyer, Richard P ^a   Jin, Jinghua ^a   Alvord Jr , Ellsworth C ^a   Mikheev, Andrei M ^a   Matthews, Russell T ^b   Pan, Catherine ^a   Khorasani, Leila ^a   Sonnen, Josh A ^a   Montine, Thomas J ^a   Shi, Min ^a   Zhang, Jing ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

1p19q deletion; BCAN; BEHAB; Microcapillary liquid chromatography mass spectrometry; Oligodendroglioma

Indexed keywords

ISOTOPE; PROTEION BCAN; SCLEROPROTEIN; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIOINFORMATICS; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CELL FRACTIONATION; CELL MIGRATION; CELL NUCLEUS; CHROMOSOME 1P; CLINICAL ARTICLE; CYTOSOL; FEMALE; GENE DELETION; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MITOCHONDRION; MOLECULAR MECHANICS; OLIGODENDROGLIOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEOMICS; QUANTITATIVE ANALYSIS;

ADULT; AGED; BLOTTING, WESTERN; CHROMATOGRAPHY, LIQUID; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; FEMALE; GENE DELETION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; ISOTOPE LABELING; MALE; MASS SPECTROMETRY; MIDDLE AGED; OLIGODENDROGLIOMA; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SUBCELLULAR FRACTIONS;

EID: 77952053290     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100054v     Document Type: Article

References (48)

1. Cairncross, J. G.; Macdonald, D. R. Successful chemotherapy for recurrent malignant oligodendroglioma Ann. Neurol. 1988, 23 (4) 360-4
2. Cairncross, G.; Berkey, B.; Shaw, E.; Jenkins, R.; Scheithauer, B.; Brachman, D.; Buckner, J.; Fink, K.; Souhami, L.; Laperierre, N.; Mehta, M.; Curran, W. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402 J. Clin. Oncol. 2006, 24 (18) 2707-14
3. Cairncross, J. G.; Ueki, K.; Zlatescu, M. C.; Lisle, D. K.; Finkelstein, D. M.; Hammond, R. R.; Silver, J. S.; Stark, P. C.; Macdonald, D. R.; Ino, Y.; Ramsay, D. A.; Louis, D. N. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas J. Natl. Cancer Inst. 1998, 90 (19) 1473-9
4. Reifenberger, G.; Louis, D. N. Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology J. Neuropathol. Exp. Neurol. 2003, 62 (2) 111-26
5. Ino, Y.; Betensky, R. A.; Zlatescu, M. C.; Sasaki, H.; Macdonald, D. R.; Stemmer-Rachamimov, A. O.; Ramsay, D. A.; Cairncross, J. G.; Louis, D. N. Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis Clin. Cancer Res. 2001, 7 (4) 839-45
6. Smith, J. S.; Perry, A.; Borell, T. J.; Lee, H. K.; OFallon, J.; Hosek, S. M.; Kimmel, D.; Yates, A.; Burger, P. C.; Scheithauer, B. W.; Jenkins, R. B. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas J. Clin. Oncol. 2000, 18 (3) 636-45
7. Walker, C.; du Plessis, D. G.; Joyce, K. A.; Fildes, D.; Gee, A.; Haylock, B.; Husband, D.; Smith, T.; Broome, J.; Warnke, P. C. Molecular pathology and clinical characteristics of oligodendroglial neoplasms Ann. Neurol. 2005, 57 (6) 855-65
8. Kanner, A. A.; Staugaitis, S. M.; Castilla, E. A.; Chernova, O.; Prayson, R. A.; Vogelbaum, M. A.; Stevens, G.; Peereboom, D.; Suh, J.; Lee, S. Y.; Tubbs, R. R.; Barnett, G. H. The impact of genotype on outcome in oligodendroglioma: validation of the loss of chromosome arm 1p as an important factor in clinical decision making J. Neurosurg. 2006, 104 (4) 542-50
9. Weller, M.; Berger, H.; Hartmann, C.; Schramm, J.; Westphal, M.; Simon, M.; Goldbrunner, R.; Krex, D.; Steinbach, J. P.; Ostertag, C. B.; Loeffler, M.; Pietsch, T.; von Deimling, A. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker Clin. Cancer Res. 2007, 13 (23) 6933-7
10. Bergquist, J.; Gobom, J.; Blomberg, A.; Roepstorff, P.; Ekman, R. Identification of nuclei associated proteins by 2D-gel electrophoresis and mass spectrometry J. Neurosci. Methods 2001, 109 (1) 3-11
11. Fountoulakis, M.; Berndt, P.; Langen, H.; Suter, L. The rat liver mitochondrial proteins Electrophoresis 2002, 23 (2) 311-28
12. Link, A. J.; Eng, J.; Schieltz, D. M.; Carmack, E.; Mize, G. J.; Morris, D. R.; Garvik, B. M.; Yates, J. R., 3rd. Direct analysis of protein complexes using mass spectrometry Nat. Biotechnol. 1999, 17 (7) 676-82
13. Rappsilber, J.; Ryder, U.; Lamond, A. I.; Mann, M. Large-scale proteomic analysis of the human spliceosome Genome Res. 2002, 12 (8) 1231-45 (Pubitemid 41264425)
14. Gygi, S. P.; Rist, B.; Gerber, S. A.; Turecek, F.; Gelb, M. H.; Aebersold, R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags Nat. Biotechnol. 1999, 17 (10) 994-9
15. Jin, J.; Meredith, G. E.; Chen, L.; Zhou, Y.; Xu, J.; Shie, F. S.; Lockhart, P.; Zhang, J. Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinsons disease Brain Res. Mol. Brain Res. 2005, 134 (1) 119-38
16. Zhang, J.; Goodlett, D. R.; Peskind, E. R.; Quinn, J. F.; Zhou, Y.; Wang, Q.; Pan, C.; Yi, E.; Eng, J.; Aebersold, R. H.; Montine, T. J. Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid Neurobiol. Aging 2005, 26 (2) 207-27
17. Zhang, J.; Goodlett, D. R.; Quinn, J. F.; Peskind, E.; Kaye, J. A.; Zhou, Y.; Pan, C.; Yi, E.; Eng, J.; Wang, Q.; Aebersold, R. H.; Montine, T. J. Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease J. Alzheimers Dis. 2005, 7 (2) 125-33 and discussion 173-80
18. Zhang, R.; Tremblay, T. L.; McDermid, A.; Thibault, P.; Stanimirovic, D. Identification of differentially expressed proteins in human glioblastoma cell lines and tumors Glia 2003, 42 (2) 194-208
19. Zhou, Y.; Gu, G.; Goodlett, D. R.; Zhang, T.; Pan, C.; Montine, T. J.; Montine, K. S.; Aebersold, R. H.; Zhang, J. Analysis of alpha-synuclein- associated proteins by quantitative proteomics J. Biol. Chem. 2004, 279 (37) 39155-64
20. Keller, A.; Nesvizhskii, A. I.; Kolker, E.; Aebersold, R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search Anal. Chem. 2002, 74 (20) 5383-92
21. Li, X. J.; Zhang, H.; Ranish, J. A.; Aebersold, R. Automated statistical analysis of protein abundance ratios from data generated by stable-isotope dilution and tandem mass spectrometry Anal. Chem. 2003, 75 (23) 6648-57
22. Gentleman, R. C.; Carey, V. J.; Bates, D. M.; Bolstad, B.; Dettling, M.; Dudoit, S.; Ellis, B.; Gautier, L.; Ge, Y.; Gentry, J.; Hornik, K.; Hothorn, T.; Huber, W.; Iacus, S.; Irizarry, R.; Leisch, F.; Li, C.; Maechler, M.; Rossini, A. J.; Sawitzki, G.; Smith, C.; Smyth, G.; Tierney, L.; Yang, J. Y.; Zhang, J. Bioconductor: open software development for computational biology and bioinformatics Genome Biol. 2004, 5 (10) R80
23. Alexa, A.; Rahnenfuhrer, J.; Lengauer, T. Improved scoring of functional groups from gene expression data by decorrelating GO graph structure Bioinformatics 2006, 22 (13) 1600-7
24. Abdi, F.; Quinn, J. F.; Jankovic, J.; McIntosh, M.; Leverenz, J. B.; Peskind, E.; Nixon, R.; Nutt, J.; Chung, K.; Zabetian, C.; Samii, A.; Lin, M.; Hattan, S.; Pan, C.; Wang, Y.; Jin, J.; Zhu, D.; Li, G. J.; Liu, Y.; Waichunas, D.; Montine, T. J.; Zhang, J. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders J. Alzheimers Dis. 2006, 9 (3) 293-348
25. Shi, M.; Jin, J.; Wang, Y.; Beyer, R. P.; Kitsou, E.; Albin, R. L.; Gearing, M.; Pan, C.; Zhang, J. Mortalin: a protein associated with progression of Parkinson disease J. Neuropathol. Exp. Neurol. 2008, 67 (2) 117-24
26. Jin, J.; Hulette, C.; Wang, Y.; Zhang, T.; Pan, C.; Wadhwa, R.; Zhang, J. Proteomic identification of a stress protein, mortalin/mthsp70/GRP75: relevance to Parkinson disease Mol. Cell. Proteomics 2006, 5 (7) 1193-204
27. Domon, B.; Aebersold, R. Mass spectrometry and protein analysis Science 2006, 312 (5771) 212-7
28. Pan, S.; Shi, M.; Jin, J.; Albin, R. L.; Lieberman, A.; Gearing, M.; Lin, B.; Pan, C.; Yan, X.; Kashima, D. T.; Zhang, J. Proteomics identification of proteins in human cortex using multidimensional separations and MALDI tandem mass spectrometer Mol. Cell. Proteomics 2007, 6 (10) 1818-23
29. Pan, S.; Zhu, D.; Quinn, J. F.; Peskind, E. R.; Montine, T. J.; Lin, B.; Goodlett, D. R.; Taylor, G.; Eng, J.; Zhang, J. A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry Proteomics 2007, 7 (3) 469-73
30. Shi, M.; Bradner, J.; Bammler, T. K.; Eaton, D. L.; Zhang, J.; Ye, Z.; Wilson, A. M.; Montine, T. J.; Pan, C.; Zhang, J. Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression Am. J. Pathol. 2009, 175 (1) 54-65
31. Zhang, J. Proteomics of human cerebrospinal fluid-the good, the bad, and the ugly Proteomics Clin. Appl. 2007, 1 (8) 805-819
32. Viapiano, M. S.; Bi, W. L.; Piepmeier, J.; Hockfield, S.; Matthews, R. T. Novel tumor-specific isoforms of BEHAB/brevican identified in human malignant gliomas Cancer Res. 2005, 65 (15) 6726-33
33. Viapiano, M. S.; Hockfield, S.; Matthews, R. T. BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion J. Neurooncol. 2008, 88 (3) 261-72
34. Okamoto, H.; Li, J.; Glasker, S.; Vortmeyer, A. O.; Jaffe, H.; Robison, R. A.; Bogler, O.; Mikkelsen, T.; Lubensky, I. A.; Oldfield, E. H.; Zhuang, Z. Proteomic comparison of oligodendrogliomas with and without 1pLOH Cancer Biol. Ther. 2007, 6 (3) 391-6
35. Ferrer-Luna, R.; Mata, M.; Nunez, L.; Calvar, J.; Dasi, F.; Arias, E.; Piquer, J.; Cerda-Nicolas, M.; Taratuto, A. L.; Sevlever, G.; Celda, B.; Martinetto, H. Loss of heterozygosity at 1p-19q induces a global change in oligodendroglial tumor gene expression J. Neurooncol. 2009, 95 (3) 343-54
36. Mukasa, A.; Ueki, K.; Ge, X.; Ishikawa, S.; Ide, T.; Fujimaki, T.; Nishikawa, R.; Asai, A.; Kirino, T.; Aburatani, H. Selective expression of a subset of neuronal genes in oligodendroglioma with chromosome 1p loss Brain Pathol. 2004, 14 (1) 34-42
37. Ducray, F.; Idbaih, A.; de Reynies, A.; Bieche, I.; Thillet, J.; Mokhtari, K.; Lair, S.; Marie, Y.; Paris, S.; Vidaud, M.; Hoang-Xuan, K.; Delattre, O.; Delattre, J. Y.; Sanson, M. Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile Mol. Cancer 2008, 7, 41
38. Ducray, F.; Criniere, E.; Idbaih, A.; Mokhtari, K.; Marie, Y.; Paris, S.; Navarro, S.; Laigle-Donadey, F.; Dehais, C.; Thillet, J.; Hoang-Xuan, K.; Delattre, J. Y.; Sanson, M. alpha-Internexin expression identifies 1p19q codeleted gliomas Neurology 2009, 72 (2) 156-61
39. Kroemer, G.; Pouyssegur, J. Tumor cell metabolism: cancers Achilles heel Cancer Cell 2008, 13 (6) 472-82
40. Hu, B.; Kong, L. L.; Matthews, R. T.; Viapiano, M. S. The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motility J. Biol. Chem. 2008, 283 (36) 24848-59
41. Matthews, R. T.; Gary, S. C.; Zerillo, C.; Pratta, M.; Solomon, K.; Arner, E. C.; Hockfield, S. Brain-enriched hyaluronan binding (BEHAB)/brevican cleavage in a glioma cell line is mediated by a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family member J. Biol. Chem. 2000, 275 (30) 22695-703
42. Nakada, M.; Miyamori, H.; Kita, D.; Takahashi, T.; Yamashita, J.; Sato, H.; Miura, R.; Yamaguchi, Y.; Okada, Y. Human glioblastomas overexpress ADAMTS-5 that degrades brevican Acta Neuropathol. (Berlin) 2005, 110 (3) 239-46
43. Gunal, A.; Onguru, O.; Safali, M.; Beyzadeoglu, M. Fascin expression [corrected] in glial tumors and its prognostic significance in glioblastomas Neuropathology 2008, 28 (4) 382-6
44. Hwang, J. H.; Smith, C. A.; Salhia, B.; Rutka, J. T. The role of fascin in the migration and invasiveness of malignant glioma cells Neoplasia 2008, 10 (2) 149-59
45. Peraud, A.; Mondal, S.; Hawkins, C.; Mastronardi, M.; Bailey, K.; Rutka, J. T. Expression of fascin, an actin-bundling protein, in astrocytomas of varying grades Brain Tumor Pathol. 2003, 20 (2) 53-8
46. Giese, A.; Bjerkvig, R.; Berens, M. E.; Westphal, M. Cost of migration: invasion of malignant gliomas and implications for treatment J. Clin. Oncol. 2003, 21 (8) 1624-36
47. Chirasani, S. R.; Markovic, D. S.; Synowitz, M.; Eichler, S. A.; Wisniewski, P.; Kaminska, B.; Otto, A.; Wanker, E.; Schafer, M.; Chiarugi, P.; Meier, J. C.; Kettenmann, H.; Glass, R. Transferrin-receptor-mediated iron accumulation controls proliferation and glutamate release in glioma cells J. Mol. Med. 2009, 87 (2) 153-67
48. Recht, L. D.; Griffin, T. W.; Raso, V.; Salimi, A. R. Potent cytotoxicity of an antihuman transferrin receptor-ricin A-chain immunotoxin on human glioma cells in vitro Cancer Res. 1990, 50 (20) 6696-700